Abstract CT203: Report of a first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640
Year: 2015
Type: conference-abstract
Source: Cancer Research
Institutions: Sarah Cannon, Tennessee Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1665596418
